reports

Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran

BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed…

3 weeks ago

IRBM Reports Breakthrough in Zika Virus Drug Discovery

ROME, Feb. 10, 2026 /PRNewswire/ -- IRBM, a leader in early drug discovery research, has announced a major scientific breakthrough…

3 weeks ago

SEMI Reports 2025 Annual Worldwide Silicon Wafer Shipments and Revenue Results

Shipments Increase in 2025 Amid Strong AI-driven Demand, While Revenue SoftensMILPITAS, Calif., Feb. 10, 2026 /PRNewswire/ -- Worldwide silicon wafer…

4 weeks ago

MerryLife Biomedical Reports Positive Phase 1 Results and Plans for Global Phase 2 Trial for TML-6, an Oral Multi-Targeted Investigational Therapy for Alzheimer’s Disease

TAINAN, Feb. 10, 2026 /PRNewswire/ -- MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive…

4 weeks ago

ASML reports transactions under its current share buyback program

February 09, 2026 08:00 ET  | Source: ASML Netherlands BV ASML reports transactions under its current share buyback program VELDHOVEN,…

4 weeks ago

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix,…

4 weeks ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE)…

4 weeks ago

Ferrero Group reports Consolidated Financial Statements for the 2024/2025 Financial Year

Ferrero Group maintains its growth trajectory with a 4.6% increase in turnover to EUR 19.3 billion.Strategy of innovation, portfolio expansion…

4 weeks ago

Hexaware Reports CY25 Revenue of USD 1,537.4 Mn, Marking 7.6% YoY Growth Q4CY25 Revenue at USD 389 Mn, Up 4.5% YoY, EBITDA Expands by 65 bps YoY

MUMBAI, India, Feb. 4, 2026 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), a global provider of IT solutions and services, today…

1 month ago

Star Health reports 414% YoY Ind AS Profit growth to 449 Cr for Q3 FY26

Q3 Combined Ratio improves 317 bps to 98.9% driven by Loss Ratio moderationCHENNAI, India, Jan. 30, 2026 /PRNewswire/ -- Star Health…

1 month ago